Normal viability, myocardial hypoplasia, and diminished cardiac performance due to monoallelic Prdm16 inactivation suggest that Prdm16csp1/wt mice are a suitable model to explore early pathophysiological changes in PRDM16 associated cardiomyopathy. This evidence concerns the gene PRDM16 and cardiomyopathy.